4.7 Article

Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 19, Issue 18, Pages 5409-5419

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2011.07.056

Keywords

Anti-breast cancer; SERM; Anti-implantation; Raloxifene; Osteoporosis

Funding

  1. Ministry of Health and Family Welfare, New Delhi
  2. DST, New Delhi
  3. Council of Scientific and Industrial Research, Government of India
  4. University Grant Commission

Ask authors/readers for more resources

A new series of 1,3-biarylsulfanyl derivatives (homodibenzyl core motif) have been designed and synthesized as new estrogen receptor ligands by chopping benzothiophene core of raloxifene to engender secoraloxifene scaffold. All the synthesized compounds were screened for anti-proliferative, anti-osteoporotic, and anti-implantation activity. Compounds (35, 36) having basic amino anti-estrogenic side chain were exhibiting potential anti-proliferative activity in MCF-7, MDA-MB-231 and ishikawa cell lines. Some of the synthesized compounds having homodibenzyl motif (5, 8, 10) have shown moderate anti-osteoporotic activity. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available